This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Nike (NKE) Stock Moves -0.14%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $118.68 in the latest trading session, marking a -0.14% move from the prior day.
Buy Lululemon Stock at a Big Discount and Hold for Years?
by Benjamin Rains
Investors might want to consider buying Lululemon as a long-term retail play because its growth outlook is impressive, as are many of its other fundamentals.
Caleres Inc. (CAL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Caleres Inc. (CAL) delivered earnings and revenue surprises of 60.98% and 11.20%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Nike (NKE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $108.63 in the latest trading session, marking a +0.58% move from the prior day.
Nike (NKE) Stock Moves -0.36%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $112.60 in the latest trading session, marking a -0.36% move from the prior day.
Nike (NKE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nike (NKE) closed at $109.49, marking a -1.55% move from the previous day.
Nike (NKE) Stock Moves -1.85%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed the most recent trading day at $124.70, moving -1.85% from the previous trading session.
The Zacks Analyst Blog Highlights Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service
by Zacks Equity Research
Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service have been included in this Analyst Blog.
Top Analyst Reports for Visa, Walt Disney & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), The Walt Disney Company (DIS), and Abbott Laboratories (ABT).
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Bear of the Day: Foot Locker (FL)
by Madeleine Johnson
Can this athletic shoe retailer win back market share now that its biggest supplier is cutting back product?
Most Indexes End Shortened Week Lower; Twitter Board Meets
by Mark Vickery
The Twitter board is holding an "all hands" meeting to decide the company's next move.
CRI or NKE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike
by Zacks Equity Research
UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike have been included in this Analyst Blog.
Top Research Reports for UnitedHealth, Johnson & Johnson, & Alibaba
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), and Alibaba Group Holding Limited (BABA).
2 ETFs & Stocks to Tap the Metaverse Boom
by Sanghamitra Saha
The concept of Metaverse is an emerging one right now. ProShares launched a Metaverse ETF this month, namely VERS. Plus, there is another ETF called Roundhill Ball Metaverse ETF (METV).
Company News for Mar 23, 2022
by Zacks Equity Research
Companies in The News Are: CCL,GDS,NKE,OKTA
Powell Hints at Higher Interest Rate Hikes in Coming Months
by Zacks Equity Research
Powell Hints at Higher Interest Rate Hikes in Coming Months
Markets Fill in Gaps from Monday's Losses
by Mark Vickery
Pre-market indexes are back in flux, following last week's rate hike, but a week away from new monthly employment data.
NIKE (NKE) Rises on High Demand as Q3 Earnings & Revenue Beat
by Zacks Equity Research
Despite the supply-chain woes, Nike's (NKE) Q3 results gained from solid demand, compelling products, and strength in its digital and DTC businesses, as well as North American and Europe regions.
Range-Bound S&P 500 Between 50-Day & 200-Day MAs After Last Week's Jay Powell Rally
by Daniel Laboe
It's difficult to get too optimistic about public equities with the VIX remaining buoyantly in the mid-20s
Nike (NKE) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of 19.18% and 2.54%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Market Futures Lower Ahead of Opening
by Zacks Equity Research
Market Futures Lower Ahead of Opening
Market Indexes' Winning Streak in Jeopardy?
by Mark Vickery
Pre-market futures are giving back a little now, with the Dow -70 points, the Nasdaq -50 and the S&P 500 -3 points.
FedEx, Oracle, Nike, Darden Restaurants, and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
FedEx, Oracle, Nike, Darden Restaurants, and JPMorgan have been highlighted in this Earnings Preview article.